Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-042653

EVP, Research & CSO sold 7,900 shares at $48.85 ($385,876)

  • EVP, Research & CSO acquired 7,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-07-14 Option exercise +7,900 $1.53 $12,087 7,900 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2020-07-14 Sale −7,900 $48.85 $385,876 0 D: show line 2 in the form
Open-market sales · 7,900 sh · avg $48.85 · $385,876

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-07-14 Option exercise · Stock Option (Right to Buy) −7,900 516,055 D: show line 3 in the form
Loading xslF345X03/doc4.xml…